277 related articles for article (PubMed ID: 12095536)
1. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein.
Di Marco MP; Edwards DJ; Wainer IW; Ducharme MP
Life Sci; 2002 Jul; 71(10):1149-60. PubMed ID: 12095536
[TBL] [Abstract][Full Text] [Related]
2. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein.
Edwards DJ; Fitzsimmons ME; Schuetz EG; Yasuda K; Ducharme MP; Warbasse LH; Woster PM; Schuetz JD; Watkins P
Clin Pharmacol Ther; 1999 Mar; 65(3):237-44. PubMed ID: 10096255
[TBL] [Abstract][Full Text] [Related]
3. Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity.
Ducharme J; Abdullah S; Wainer IW
J Chromatogr B Biomed Appl; 1996 Mar; 678(1):113-28. PubMed ID: 8861661
[TBL] [Abstract][Full Text] [Related]
4. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins.
Malhotra S; Bailey DG; Paine MF; Watkins PB
Clin Pharmacol Ther; 2001 Jan; 69(1):14-23. PubMed ID: 11180034
[TBL] [Abstract][Full Text] [Related]
5. Grapefruit juice activates P-glycoprotein-mediated drug transport.
Soldner A; Christians U; Susanto M; Wacher VJ; Silverman JA; Benet LZ
Pharm Res; 1999 Apr; 16(4):478-85. PubMed ID: 10227700
[TBL] [Abstract][Full Text] [Related]
6. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.
Lown KS; Bailey DG; Fontana RJ; Janardan SK; Adair CH; Fortlage LA; Brown MB; Guo W; Watkins PB
J Clin Invest; 1997 May; 99(10):2545-53. PubMed ID: 9153299
[TBL] [Abstract][Full Text] [Related]
7. Effect of Seville orange juice and grapefruit juice on indinavir pharmacokinetics.
Penzak SR; Acosta EP; Turner M; Edwards DJ; Hon YY; Desai HD; Jann MW
J Clin Pharmacol; 2002 Oct; 42(10):1165-70. PubMed ID: 12362932
[TBL] [Abstract][Full Text] [Related]
8. Effects of grapefruit and Seville orange juices on the pharmacokinetic properties of colchicine in healthy subjects.
Wason S; DiGiacinto JL; Davis MW
Clin Ther; 2012 Oct; 34(10):2161-73. PubMed ID: 22940371
[TBL] [Abstract][Full Text] [Related]
9. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
[TBL] [Abstract][Full Text] [Related]
10. Dramatic inhibition of amiodarone metabolism induced by grapefruit juice.
Libersa CC; Brique SA; Motte KB; Caron JF; Guédon-Moreau LM; Humbert L; Vincent A; Devos P; Lhermitte MA
Br J Clin Pharmacol; 2000 Apr; 49(4):373-8. PubMed ID: 10759694
[TBL] [Abstract][Full Text] [Related]
11. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity.
Guo LQ; Fukuda K; Ohta T; Yamazoe Y
Drug Metab Dispos; 2000 Jul; 28(7):766-71. PubMed ID: 10859150
[TBL] [Abstract][Full Text] [Related]
12. Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity.
Kashuba AD; Nafziger AN; Kearns GL; Leeder JS; Gotschall R; Gaedigk A; Bertino JS
Pharmacogenetics; 1999 Aug; 9(4):453-62. PubMed ID: 10780265
[TBL] [Abstract][Full Text] [Related]
13. Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.
Edwards DJ; Bellevue FH; Woster PM
Drug Metab Dispos; 1996 Dec; 24(12):1287-90. PubMed ID: 8971132
[TBL] [Abstract][Full Text] [Related]
14. A urine metabolic ratio of dextromethorphan and 3-methoxymorphinan as a probe for CYP3A activity and prediction of cyclosporine clearance in healthy volunteers.
Min DI; Ku YM; Vichiendilokkul A; Fleckenstein LL
Pharmacotherapy; 1999 Jun; 19(6):753-9. PubMed ID: 10391422
[TBL] [Abstract][Full Text] [Related]
15. Undesirable effects of citrus juice on the pharmacokinetics of drugs: focus on recent studies.
Saito M; Hirata-Koizumi M; Matsumoto M; Urano T; Hasegawa R
Drug Saf; 2005; 28(8):677-94. PubMed ID: 16048354
[TBL] [Abstract][Full Text] [Related]
16. A sensitive LC-MS/MS assay for the determination of dextromethorphan and metabolites in human urine--application for drug interaction studies assessing potential CYP3A and CYP2D6 inhibition.
Vengurlekar SS; Heitkamp J; McCush F; Velagaleti PR; Brisson JH; Bramer SL
J Pharm Biomed Anal; 2002 Aug; 30(1):113-24. PubMed ID: 12151071
[TBL] [Abstract][Full Text] [Related]
17. Effects of grapefruit juice on intestinal P-glycoprotein: evaluation using digoxin in humans.
Parker RB; Yates CR; Soberman JE; Laizure SC
Pharmacotherapy; 2003 Aug; 23(8):979-87. PubMed ID: 12921244
[TBL] [Abstract][Full Text] [Related]
18. Effect of grapefruit juice on urinary 6 beta-hydroxycortisol/cortisol excretion.
Seidegård J; Dahlström K; Kullberg A
Clin Exp Pharmacol Physiol; 1998 May; 25(5):379-81. PubMed ID: 9612666
[TBL] [Abstract][Full Text] [Related]
19. Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine.
Paine MF; Widmer WW; Pusek SN; Beavers KL; Criss AB; Snyder J; Watkins PB
Am J Clin Nutr; 2008 Apr; 87(4):863-71. PubMed ID: 18400708
[TBL] [Abstract][Full Text] [Related]
20. Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice.
Greenblatt DJ; von Moltke LL; Harmatz JS; Chen G; Weemhoff JL; Jen C; Kelley CJ; LeDuc BW; Zinny MA
Clin Pharmacol Ther; 2003 Aug; 74(2):121-9. PubMed ID: 12891222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
